Article
Whole-genome CRISPR screening identifies genetic manipulations to reduce immune rejection of stem cell-derived islets
1 Sept 2022
Abstract excerpt
Human embryonic stem cells (hESCs) provide opportunities for cell replacement therapy of insulin-dependent diabetes. Therapeutic quantities of human stem cell-derived islets (SC-islets) can be produced by directed differentiation. However, preventing allo-rejection and recurring autoimmunity, without the use of encapsulation or systemic immunosuppressants, remains a challenge. An attractive approach is to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
